[Effect of antirheumatic preparations on the level of glycosaminoglycans in patients with rheumatism].
D000293:Adolescent; D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D005260:Female; D006025:Glycosaminoglycans / Q000378:metabolism*; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D012213:Rheumatic Fever / Q000188:drug therapy* / Q000378:metabolism; D012459:Salicylates / Q000627:therapeutic use
D045930:Anabolic Agents; D000893:Anti-Inflammatory Agents; D006025:Glycosaminoglycans; D011720:Pyrazoles; D011804:Quinolines; D012459:Salicylates; D011239:Prednisolone; D007213:Indomethacin
Vliianie antirevmaticheskikh preparatov na uroven' glikozaminglikanov u bol'nykh revmatizmom